MAGDALENE DOBIJA: Open Payments
NPI 1649954728 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 13 payments from 7 companies in 2025. Trend: 2023 $40 · 2024 $257 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
| Saluda Medical Americas, Inc. | 3 | $50 |
| PFIZER INC. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| SPR Therapeutics, Inc | 1 | $9 |
Products named: QULIPTA, RELISTOR, Evoke, NURTEC ODT, Belbuca, JOURNAVX, SPRINT PNS System.
Industry payments across CO — which companies pay providers there.
